ORIGINAL TSCNO-COFIDENTIAL BUSINESS INFORMATION DOCUMENT DESCRIPTION SEHQ- qa9.-bs 1

First Page		Document Content
Date: 2011-06-08 11:21:09 Toxicology Euphoriants Organosulfate Toxic Substances Control Act Sodium compounds		ORIGINAL TSCNO-COFIDENTIAL BUSINESS INFORMATION DOCUMENT DESCRIPTION SEHQ- qa9.-bs 1 Add to Reading List Source URL: www.epa.gov Download Document from Source Website File Size: 2,31 MB Share Document on Facebook

	Microsoft Word - VLD Packet.FINAL DocID: 1rubZ - View Document
	Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compa DocID: 1rtjz - View Document
	TITAN PHARMACEUTICALS CORPORATE PRESENTATION SUNIL BHONSLE JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. NASDAQ:TTNP DocID: 1rsmr - View Document
	“Hokus-Pokus Palliative Care” Case Report Gabriela Popescu, MD, M.Sc. Palliative Care, FMH Internal Medicine Tumor Zentrum and Hirslanden Klinik Aarau DocID: 1rsfZ - View Document
	Sunil Bhonsle Mar 2015 Corporate Presentation DocID: 1rrwl - View Document